Portfolio map · Corporate investor · United States
Eli Lilly portfolio map
86 startups Eli Lilly has backed in rounds we track, since 2003, grouped by their main sector. Together they have raised $12B. The biggest sector is Biotech, with 55 companies.
86startups backed
4sectors
$12Braised between them
Biotechbiggest sector
Biotech
55Avidity Biosciences
Terns Pharmaceuticals
AbCellera
AdvanCell- IMInsilico Medicine
Beta Bionics
T-Therapeutics
Verve Therapeutics
Cabaletta Bio
Circle Pharma
Lycia Therapeutics
Mariana Oncology- CTCapstan Therapeutics
Aktis Oncology
Vanqua Bio
SonoThera
Myricx Bio- PSPerlegen Sciences
- DPDTx Pharma
Firefly Bio
Syndeio Biosciences
Stylus Medicine
Faze Medicines
Cedilla Therapeutics
+31 more
AI
13
Funding by segment
- Biotech$6.7B55
- AI$1.4B13
- Healthtech$3.4B10
- Pharma$492M8
Where they are based
- United States63$6.5B
- United Kingdom6$482M
- Canada3$542M
- Australia2$461M
- Hong Kong SAR China1$392M
- Netherlands1$68M
- Switzerland1$67M
- France1$37M
- South Korea1$18M
- Singapore1$14M
United States
United Kingdom
Canada
Australia
Hong Kong SAR China
Netherlands
Switzerland
France
South Korea
SingaporeFounded
4Earlier
512
313
14
415
516
617
618
1219
520
1321
922
223
124
125
26
10 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M9
- $10M to $50M28
- $50M to $250M38
- $250M to $1B9
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
75 of 86 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States63
- United Kingdom6
- Canada3
- Australia2
- Hong Kong SAR China1
- Netherlands1
- Switzerland1
- France1
- South Korea1
- Singapore1
- Finland1
- Denmark1
Finland
DenmarkStartups by country, 14 countries in all.
Segment by segment
Biotech
55 startups · $6.7B raised
- Terns PharmaceuticalsTerns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.United States$730M
- AbCelleraAbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.Canada$526M
- AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M
- IMInsilico MedicineHong Kong SAR China$392M
- Beta BionicsBeta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.United States$296M
- T-TherapeuticsT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.United Kingdom$279M
- Verve TherapeuticsVerve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.United States$202M
AI
13 startups · $1.4B raised
Alto NeuroscienceAlto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.United States$270M
DELFI DiagnosticsDELFI Diagnostics is a biotechnology company founded in 2019 that focuses on early cancer detection through a blood-based liquid bUnited States$259M
Iterative HealthIterative Health is a healthcare technology and services company based in Cambridge, Massachusetts, with an additional office in NUnited States$227M
BigHat BiosciencesBigHat Biosciences is a biotechnology company founded in 2019 and based in San Mateo, California.United States$150M
AbsciAbsci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential oUnited States$150M
Moonwalk BiosciencesMoonwalk Biosciences is an early-stage, pre-clinical therapeutics company based in South San Francisco, California, with an additiUnited States$127M
Rezo TherapeuticsRezo Therapeutics is a biopharmaceutical company based in San Francisco, founded in 2021.United States$78M
Excelsior SciencesExcelsior Sciences is a biotechnology company based in New York City, founded in 2024.United States$70M
Healthtech
10 startups · $3.4B raised
- OOuraFinland$2.9B
Orbis MedicinesOrbis Medicines is a biotechnology company based in Copenhagen, Denmark, with an additional presence in Lausanne, Switzerland.Denmark$187M
General MedicineGeneral Medicine is a healthcare technology startup founded in 2023 by former Amazon leaders TJ Parker, Elliot Cohen, and Ashwin MUnited States$152M
Companion MedicalCompanion Medical develops a technology designed for those living with Type 1 or Type 2 insulin-dependent diabetes.United States$31M
Leal TherapeuticsLeal Therapeutics is a biopharmaceutical company based in Worcester, Massachusetts, founded in 2021.United States$30M
updocUpDoc is a clinical AI company based in Palo Alto, California, founded in 2023.Australia$23M
Signify BioSignify Bio is a biotechnology company based in Dallas, Texas, founded in 2024.United States$15M
Radar TherapeuticsRadar Therapeutics is a biotechnology company based in Berkeley, California, founded in November 2022.United States$13M
Pharma
8 startups · $492M raised
Flare TherapeuticsFlare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021.United States$123M
Augustine TherapeuticsAugustine Therapeutics is a Belgian biotechnology company founded in 2019 and based in Leuven.Belgium$84M
Ratio TherapeuticsRatio Therapeutics is a Boston-based clinical-stage pharmaceutical company founded in 2021.United States$70M
OrsoBioOrsoBio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for severe metabolic disorders, iUnited States$67M
Ampersand BiomedicinesAmpersand Biomedicines is a biotechnology startup based in Boston, founded in 2021 by Flagship Pioneering.United States$65M
ViaNautisViaNautis, founded in 2018 as a spin-off from University College London, is a biotechnology company based in Cambridge, United Kingdom.United Kingdom$52M
Artax BiopharmaArtax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.United States$21M
Prism BioLabPrism is a biotechnology company that develops therapeutic drugs that cure intractable diseases using unique peptide mimic technology.Japan$10M
Belgium
JapanHow this map is made. Every startup here has raised money in a round we track that names Eli Lilly as an investor, the first in 2003. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosCorporate investor · United StatesGoogle Ventures350 startups · 12 sectors · $99BCorporate investor · United StatesCoinbase Ventures305 startups · 12 sectors · $16BCorporate investor · United StatesIntel Capital295 startups · 12 sectors · $23BCorporate investor · United StatesSalesforce Ventures290 startups · 12 sectors · $200BCorporate investor · United StatesEndeavor Catalyst181 startups · 12 sectors · $22BCorporate investor · United StatesSamsung Next170 startups · 12 sectors · $15B
Raising from investors like Eli Lilly?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.